Search Results

Showing results 41 - 50 of 2032.
Sort By: Date ▼

HPV vaccinations cut rates of precancerous lesions in half among teens, study finds

July 3, 2019

Vaccinations against the human papillomavirus (HPV) have led to significant decreases in cases of anal and genital warts, HPV infections, and precancerous lesions in young girls and women in more than a dozen countries, providing evidence the vaccines eventually could lead to a significant drop in cervical cancer rates, according to a study published last week.

CMS OKs Louisiana's plan to get 'unlimited access' to hep C treatment

July 1, 2019

CMS last week signed off on Louisiana's plan to test a subscription-based payment model for hepatitis C drugs intended to increase medication access for its Medicaid and prison populations.

Democrats' big split in last night's debate: Whether to 'abolish' private insurers

June 27, 2019

The first batch of 2020 Democratic presidential candidates squared off in a primary debate Wednesday night, and a question regarding so-called "Medicare-for-All" proposals emerged as a dividing factor between the candidates.

Senate HELP committee advances 'surprise' bill legislative package

June 27, 2019

The Senate Health, Education, Labor and Pensions Committee on Wednesday voted 20-3 to approve a bill intended address so-called "surprise" medical bills, reduce U.S. health care costs, and more, but senators have suggested the bill could undergo more changes before a floor debate next month.

AbbVie plans to purchase Allergan, maker of Botox, for about $63B

June 26, 2019

Drugmaker AbbVie on Tuesday announced that it plans to buy Allergan, the maker of Botox, for about $63 billion in cash and stock—a deal worth $80 billion after accounting for debt.

Employer health costs are on the rise again—leading some to reimagine their approach to insurance

June 25, 2019

Employer health care costs are expected to reach a four-year high in 2020, in part due to rising prescription drug prices—and that is prompting many employers to re-think their approach to health insurance, according to a PwC Health Research Institute report released this month.

FDA approves new drug to treat low sexual desire in premenopausal women

June 24, 2019

FDA on Friday approved a drug to treat premenopausal women with low sexual desire—a condition known as hypoactive sexual desire disorder.

FDA wants to change the way it evaluates opioids. Here's how.

June 21, 2019

FDA on Thursday released draft guidance aimed at strengthening the agency's framework for reviewing new opioid drugs by comparing the safety and effectiveness of proposed products to existing products and assessing whether new products would reduce the risk of opioid misuse.

Results Page: [Previous] 1 2 3 4 5  ... [Next]